Irrationality in the management of breast cancer: I. The staging system

M. M. Nachlas

Research output: Contribution to journalArticle

Abstract

The historic development of breast cancer staging began early in the 20th century with the simple concept of early localized disease, spread to regional nodes, and the presence of distant metastases. This last group often was divided into patients with advanced but perhaps still curable locoregional disease and incurable patients with distant metastases. As increasing numbers of prognostic factors were recognized, efforts were made to incorporate them into the staging systems to combine patients with similar prognosis into the same stages. These attempts resulted in the development of four classifications, namely, the Columbia, Manchester, International, and American tumor-node-metastasis (TNM) staging systems. Although many benefits of staging were reported, the most important was that of permitting valid comparisons between different treatments and different institutions. Many success-limiting factors were noticed during the developmental years, and even though the TNM system has been accepted, numerous speakers and authors present their staged data in a confusing and ambiguous manner. Recommendations are made that would permit clarification of presentations to general medical audiences along with recognizable statistical validity.

Original languageEnglish (US)
Pages (from-to)681-690
Number of pages10
JournalCancer
Volume68
Issue number4
StatePublished - 1991

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Neoplasm Staging
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Irrationality in the management of breast cancer : I. The staging system. / Nachlas, M. M.

In: Cancer, Vol. 68, No. 4, 1991, p. 681-690.

Research output: Contribution to journalArticle

Nachlas, MM 1991, 'Irrationality in the management of breast cancer: I. The staging system', Cancer, vol. 68, no. 4, pp. 681-690.
Nachlas, M. M. / Irrationality in the management of breast cancer : I. The staging system. In: Cancer. 1991 ; Vol. 68, No. 4. pp. 681-690.
@article{b4538629858c443fa521660ed5939630,
title = "Irrationality in the management of breast cancer: I. The staging system",
abstract = "The historic development of breast cancer staging began early in the 20th century with the simple concept of early localized disease, spread to regional nodes, and the presence of distant metastases. This last group often was divided into patients with advanced but perhaps still curable locoregional disease and incurable patients with distant metastases. As increasing numbers of prognostic factors were recognized, efforts were made to incorporate them into the staging systems to combine patients with similar prognosis into the same stages. These attempts resulted in the development of four classifications, namely, the Columbia, Manchester, International, and American tumor-node-metastasis (TNM) staging systems. Although many benefits of staging were reported, the most important was that of permitting valid comparisons between different treatments and different institutions. Many success-limiting factors were noticed during the developmental years, and even though the TNM system has been accepted, numerous speakers and authors present their staged data in a confusing and ambiguous manner. Recommendations are made that would permit clarification of presentations to general medical audiences along with recognizable statistical validity.",
author = "Nachlas, {M. M.}",
year = "1991",
language = "English (US)",
volume = "68",
pages = "681--690",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Irrationality in the management of breast cancer

T2 - I. The staging system

AU - Nachlas, M. M.

PY - 1991

Y1 - 1991

N2 - The historic development of breast cancer staging began early in the 20th century with the simple concept of early localized disease, spread to regional nodes, and the presence of distant metastases. This last group often was divided into patients with advanced but perhaps still curable locoregional disease and incurable patients with distant metastases. As increasing numbers of prognostic factors were recognized, efforts were made to incorporate them into the staging systems to combine patients with similar prognosis into the same stages. These attempts resulted in the development of four classifications, namely, the Columbia, Manchester, International, and American tumor-node-metastasis (TNM) staging systems. Although many benefits of staging were reported, the most important was that of permitting valid comparisons between different treatments and different institutions. Many success-limiting factors were noticed during the developmental years, and even though the TNM system has been accepted, numerous speakers and authors present their staged data in a confusing and ambiguous manner. Recommendations are made that would permit clarification of presentations to general medical audiences along with recognizable statistical validity.

AB - The historic development of breast cancer staging began early in the 20th century with the simple concept of early localized disease, spread to regional nodes, and the presence of distant metastases. This last group often was divided into patients with advanced but perhaps still curable locoregional disease and incurable patients with distant metastases. As increasing numbers of prognostic factors were recognized, efforts were made to incorporate them into the staging systems to combine patients with similar prognosis into the same stages. These attempts resulted in the development of four classifications, namely, the Columbia, Manchester, International, and American tumor-node-metastasis (TNM) staging systems. Although many benefits of staging were reported, the most important was that of permitting valid comparisons between different treatments and different institutions. Many success-limiting factors were noticed during the developmental years, and even though the TNM system has been accepted, numerous speakers and authors present their staged data in a confusing and ambiguous manner. Recommendations are made that would permit clarification of presentations to general medical audiences along with recognizable statistical validity.

UR - http://www.scopus.com/inward/record.url?scp=0026050714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026050714&partnerID=8YFLogxK

M3 - Article

C2 - 1855167

AN - SCOPUS:0026050714

VL - 68

SP - 681

EP - 690

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -